Toomey, Deirdre <br/><br/>
Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up.  [electronic resource] 

 -  International journal of cancer  Jan 2003 
 - 408-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.10836  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Large Cell--metabolism<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Carcinoma, Squamous Cell--metabolism<br/>Fas Ligand Protein<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Lung Neoplasms--metabolism<br/>Lymphocytes, Tumor-Infiltrating--metabolism<br/>Male<br/>Membrane Glycoproteins--metabolism<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Survival Rate<br/>T-Lymphocytes--metabolism